Active surveillance for intermediate-risk prostate cancer

被引：0
|
作者：
Madhur Nayan
Filipe L. F. Carvalho
Adam S. Feldman
机构：
[1] Massachusetts General Hospital,Department of Urology
来源：
World Journal of Urology | 2022年 / 40卷
关键词：
Prostate cancer; Active surveillance; Intermediate risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：79 / 86
页数：7
相关论文
共 50 条
  • [1] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    [J]. BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [2] Active surveillance for intermediate-risk prostate cancer
    M A Dall'Era
    L Klotz
    [J]. Prostate Cancer and Prostatic Diseases, 2017, 20 : 1 - 6
  • [3] Active surveillance for intermediate-risk prostate cancer
    Dall'Era, M. A.
    Klotz, L.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (01) : 1 - 6
  • [4] Active surveillance for intermediate-risk prostate cancer
    Nayan, Madhur
    Carvalho, Filipe L. F.
    Feldman, Adam S.
    [J]. WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 79 - 86
  • [5] Is active surveillance safe for patients with intermediate-risk prostate cancer?
    Chung, Hoseok
    Shin, Bo Sung
    Nam, Deok-Hyun
    Chung, Hoseok
    Kim, Myung Ki
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    [J]. BJU INTERNATIONAL, 2015, 116 : 4 - 4
  • [6] Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
    Overland, Maya R.
    Washington, Samuel L., III
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Herlemann, Annika
    [J]. CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 605 - 611
  • [7] Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
    Courtney, P. T.
    Deka, R.
    Cherry, D. R.
    Nelson, T. J.
    Luterstein, E.
    Salans, M. A.
    Yip, A. T. T.
    Nalawade, V.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Rose, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S121 - S122
  • [8] Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Diven, Marshall A.
    Tshering, Lhaden
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher
    McClure, Timothy
    Nagar, Himanshu
    [J]. JAMA NETWORK OPEN, 2024, 7 (08)
  • [9] PROSTATE CANCER Time for active surveillance of intermediate-risk disease?
    Ahmed, Hashim U.
    [J]. NATURE REVIEWS UROLOGY, 2013, 10 (01) : 6 - 8
  • [10] Identifying intermediate-risk candidates for active surveillance of prostate cancer
    Savdie, Richard
    Aning, Jonathan
    So, Alan I.
    Black, Peter C.
    Gleave, Martin E.
    Goldenberg, S. Larry
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 605.e1 - 605.e8
12345